worth looking at 7 year chart comparison with GSK(available on www.thisismoney.co.uk);think that this could hit 180 p using this chart as a guide;a market capitalisation of £250 million would give a share price of around 150 p which is getting back towards the original estimates before the London flotation on AIM;quite possible that investors will wait for price to approach 200 p before selling.
I made it 127 but who cares? Versus 105 close in London, this is serious market pressure on the UK market makers who have manipulated this SP over many moons. Are the regulators watching? How do we alert them? No surrender!
You're a romantic, Gustavio. The price is going up because this stock looks increasingly like a big winner long term. Events driving the price include 1. Flotation on Nasdaq, 2. German agreement on pricing the medicine opens up Europe's largest market, 3. Good financial results recently, 4. Fast-track process started in US for FDA to approve Sativex for MS prescriptions in the US, 5. Impending results of trials for cancer pain relief which would lead to FDA approval in the US for this use, 6. Forward product development programme for use in diabetes, 7. Sativex is a pharma version of the weed that removes medical excuses for using it so legislators like it.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.